Idexx Laboratories (IDXX) Net Cash Flow (2009 - 2026)

Idexx Laboratories has reported Net Cash Flow for 18 years, with the latest figure at -$3.5 million in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 73.93% year-over-year to -$3.5 million in Q2 2026; TTM through Jun 2026 was $33.8 million, a 113.85% increase from a year earlier, with the FY2025 full-year figure at -$119.4 million, up 23.53% from the prior year.
• Net Cash Flow was -$3.5 million for Q2 2026 at Idexx Laboratories, down from $21.3 million in the prior quarter.
• The five-year high for Net Cash Flow was $201.6 million in Q3 2023, with the low at -$122.0 million in Q1 2025.
• Average Net Cash Flow over 5 years is $3.2 million, with a median of -$2.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow surged 7091.35% in 2022, then tumbled 3021.01% in 2024.
• Over 5 years, Net Cash Flow stood at $7.5 million in 2022, then surged by 1472.03% to $117.6 million in 2023, then tumbled by 109.02% to -$10.6 million in 2024, then slumped by 164.83% to -$28.1 million in 2025, then jumped by 87.45% to -$3.5 million in 2026.
• The last three Net Cash Flow figures came in at -$3.5 million (Q2 2026), $21.3 million (Q1 2026), and -$28.1 million (Q4 2025), per Business Quant data.